Prascend Tablets for Horses, 1mg

Supplied By: Boehringer Ingelheim (131356)


SKU
042007


Unit of
Measure
160 Count


Pack
Type
Box


Case
Qty
1

{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Dec- 2024 Nov- 2024 Oct- 2024 Sep- 2024 Aug- 2024 Jul- 2024 Jun- 2024 May- 2024 Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024 Dec- 2023
{{purchaseHistoryItem}}


SKU
042007


Size
160 Count

Case
Qty
1

Purchase History

Dec- 2024 {{productPurchaseHistory['042007'][0]}} May- 2024 {{productPurchaseHistory['042007'][0+7]}}
Nov- 2024 {{productPurchaseHistory['042007'][1]}} Apr- 2024 {{productPurchaseHistory['042007'][1+7]}}
Oct- 2024 {{productPurchaseHistory['042007'][2]}} Mar- 2024 {{productPurchaseHistory['042007'][2+7]}}
Sep- 2024 {{productPurchaseHistory['042007'][3]}} Feb- 2024 {{productPurchaseHistory['042007'][3+7]}}
Aug- 2024 {{productPurchaseHistory['042007'][4]}} Jan- 2024 {{productPurchaseHistory['042007'][4+7]}}
Jul- 2024 {{productPurchaseHistory['042007'][5]}} Dec- 2023 {{productPurchaseHistory['042007'][5+7]}}
Jun- 2024 {{productPurchaseHistory['042007'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

Prascend, also known as Pergolide, is used for the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in horses. Each Prascend Tablet contains 1 mg pergolide mesylate.

Features & Benefits

  • For horses with Cushings
  • Improved clinical signs within 3 months and continued through 6 months
  • 3 out of 4 horses evaluated were considered treatment successes
  • Hypertrichosis (delayed shedding) improved in 89% of treated horses within 6 months